You are here: Industry Insights > CDMO

News List

WuXi AppTec Appoints Advanced Therapies CEO contractpharma
June 02, 2020
Dr. Chang will provide strategic, scientific and operational leadership to the company's global cell and gene therapy R&D and manufacturing services.
CDMO delivers 4000 doses of COVID-19 vaccine candidate for Phase II/III trial europeanpharmaceuticalreview
June 01, 2020
Advent announced it has manufactured and delivered the first 4000 doses of the AZD1222 vaccine candidate for the University of Oxford clinical trial.
CDMO pledges increased production of hydroxychloroquine sulfate, potential COVID-19 treatment europeanpharmaceuticalreview
May 08, 2020
The CDMO AMRI has said it will boost its production of the malaria drug hydroxychloroquine sulfate, identified as a potential COVID-19 treatment, following an emergency use authorisation from the FDA.
CMAB Bolsters Executive Team contractpharma
April 06, 2020
CMAB Biopharma (Suzhou) Inc., a biologics contract manufacturing and development organization (CDMO), has appointed Ye Shi as the head of quality.
CMAB Biopharma Resumes Full-Scale Operation contractpharma
March 25, 2020
CMAB Biopharma has reported that its facility in Suzhou, China has now resumed full operation following the coronavirus COVID-19 outbreak.
Fujifilm Invests $83M to Expand Microbial Capacity contractpharma
March 23, 2020
Fujifilm Corporation has unveiled plans to invest approximately $83 million to expand the microbial production capacity of Fujifilm Diosynth Biotechnologies (FDB).
Chime Biologics Supports COVID-19 Outbreak in Wuhan contractpharma
March 13, 2020
Chime Biologics, a China-based contract development and manufacturing organization (CDMO) providing fully-integrated services to support development and manufacturing of complex biologic ...
Evolving World of Pharma: Spray Drying In the Pharma Industry Sarah Harding
March 04, 2020
Investments in technology are – quite rightly – frequently seen to be a strong rationale for press releases from industry players, especially those in the contract manufacturing business.
Joinn Biologics nabs $60M to use for biologics capacity fiercepharma
December 20, 2019
A Chinese-American CDMO has raised $60 million but doesn’t intend to hold onto the cash very long. Joinn Biologics says it will use most of it to build a plant to increase its biologics production ...
Vetter's Occupational Health Management Excels Again in Employee Wellness Initiatives b3cnewswire
December 18, 2019
According to studies, an ever-greater number of staff members are complaining about increasing mental stress. Nevertheless ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page